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Abstract 
The mechanisms ofamyloid formation in Familial Amyloidotic Polyneuropathy (FAP) are unknown, as well as the factors determining 
the development of this pathology. To get some insights into this process, we have first tested a fluorimetric assay with thioflavine T, as a 
quantitative method for transthyretin (TTR) amyloid estimation, using amyloid isolated from post-mortem tissues of a FAP patient. Then 
production of amyloid fibrils from soluble TTR was achieved by acidification and optimized for protein concentration a d pH. The effect 
of different ions such as metal and sulphate ions in the process of amyloid formation from wild type TTR was compared using a kinetic 
assay. Under the conditions tested sulphate diminishes the amount of amyloid formed from wild type TTR and in addition appears to 
promote aggregation of preexisting amyloid fibrils. The relative amyloidogenicity of three TTR variants, TTR Met30, TTR Pro55 and 
TTR Met119 respectively, was evaluated using a pH dependent assay. It was shown that the Pro55 variant is highly susceptible to 
amyloid formation as compared to the wild type protein; on the contrary, the Met119 variant is more resistant than the other TTR proteins 
towards precipitation into amyloid. These results are in agreement with the pathological conditions associated with these mutations. This 
type of assay has a wide application for testing the influence of other factors, such as therapeutical gents, on amyloid formation. 
Kewvords: Familial amyloidotic polyneuropathy; Transthyretin variant; Amyloid formation; Fluorimetric assay; Kinetic study; Sulfate 
1. Introduction 
Amyloid deposition is a characteristic feature of a com- 
plex group of diseases known as amyloidoses, which in- 
clude among others, familial amyloidotic polyneuropathy 
(FAP) and Alzheimer's disease [1]. These deposits are 
composed of 7-10 nm wide, rigid, nonbranching fibrils 
with variable lengths and a typical twisted beta-pleated 
sheet structure [2], presenting unique tinctorial properties 
such as apple-green birefringence under polarized light and 
yellow green fluorescence, upon staining with congo red 
and thioflavine S respectively. 
Several apparently nonrelated proteins can be found as 
main constituents of amyloid fibrils, and this chemical 
heterogeneity is associated with specific clinical forms of 
amyloidoses. Other components present in amyloid de- 
posits include serum amyloid P component [3] and gly- 
cosaminoglycans [4]. 
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In two forms of amyloidoses, FAP and senile systemic 
amyloidosis (SSA), the protein component of the amyloid 
fibrils is related to transthyretin (TTR) [5,6], a homote- 
trameric plasma protein of 55 kD that binds thyroxine and 
retinol binding protein. 
Several TTR variants have been found associated with 
FAP [7]; the most prevalent TTR mutation is TTR Met30 
where the valine at position 30 is substituted by a methion- 
ine [8]; TTR Pro55 results from a proline for leucine 
substitution at position 55 and gives rise to a particularly 
aggressive form of the disease [9]; non-amyloidogenic 
variants have also been described such as TTR Met l l9  
with a methionine for threonine substitution at position 
119 [10]. The molecular mechanisms leading to the poly- 
merization of TTR and its deposition as amyloid fibrils are 
unknown; the existence of mutations in the TTR molecule 
might favour the deposition of the protein as amyloid, 
however other factors must be involved, since the normal 
protein can also deposit as amyloid in SSA [6]. 
Using 'in vitro' amyloid formation from soluble TTR 
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preparations and a quantitative thioflavine T fluorimetric 
assay [11], that has been used for other amyloid proteins, 
we have investigated the amyloidogenic behaviour of three 
different TTR variants, TTR Met30, TTR Pro55 and TTR 
Metll9. The influence of aluminum, zinc, magnesium, 
sodium and sulfate in the process of amyloid formation 
was evaluated. 
2. Materials and methods 
2.1. Amyloid fibril isolation 
Amyloid was isolated post-mortem from the thyroid of 
a FAP patient (FAP XX) following standard procedures 
[5]. 
2.2. Protein purification 
Recombinant wild type TTR, TTR Pro55 [12], TTR 
Met30 and TTR Met119 [13] were isolated from E. coli 
and purified by preparative gel electrophoresis after ion 
exchange chromatography. Details of this procedure will 
be published elsewhere [14]. Isolated proteins were stored 
at -20°C in double distilled deionized water. 
Recombinant wild type TTR and TTR Pro55 were a gift 
from J.F. Kelly (Texas, A and M University). 
2.3. Synthetic peptide 
A synthetic peptide designated by Y649, corresponding 
to residues 28 to 33 of human TTR Met30 (asn-val-met- 
his-val-phe-spacer arm-cys), was synthesized by automatic 
solid-phase synthesis (Macromolecular Analysis Service, 
University of Birmingham, UK) and purified by HPLC. 
2.4. Amyloid formation assays 
Wild type recombinant TTR at different conditions of 
buffer, concentration, pH and time, was incubated at room 
temperature; the conditions for the several studies were as 
follows. 
2.4.1. Concentration dependence curve 
Wild type recombinant TTR at the following concentra- 
tions 0.5, 1.25, 2, 3, 4 and 5 mg/ml was incubated in 40 
/zl 100 mM acetate buffer pH 4 for 96 h. 
2.4.2. pH dependence curve 
Recombinant wild type and variant TTRs at a concen- 
tration of 2 mg/ml were incubated in 40 /zl 100 mM 
citrate/200 mM phosphate buffer at the desired pH for 96 
h. 
2.4.3. Kinetic studies 
Kinetic experiments were performed as follows; protein 
stocks in sterile double distilled deionized H20 were 
distributed into Eppendorf tubes at the appropriate concen- 
tration and stored at -20°C. 
At each time point the protein was thawed, appropriate 
buffers and metals were added to the required concentra- 
tions, and after incubation at different imes ranging be- 
tween zero and 100 h, samples were frozen until further 
analysis. All assays, in a final volume of 40 /~1, contained 
2 mg/ml TTR, 100 mM acetate buffer pH 4 and, when 
appropriate, the following salts: aluminum chloride, zinc 
chloride, magnesium chloride and sodium chloride. 
When using 50 mM sulfate the assay volume was 75 /zl 
and the samples were spun in a microfuge before being 
frozen, supernatants u ed for protein determination, pellets 
washed with double distilled deionized water and further 
analyzed by fluorimetry. 
2.4.4. Amyloid characterization 
The samples used for electron microscopy were pre- 
pared as follows: 200/zg of wild type TTR were incubated 
in 100 mM acetate buffer pH 4, final volume 100 pA, for 
120 h. The suspensions obtained were neutralized with 
25% ammonia solution, the volume was adjusted to 1 ml 
and centrifuged for 4 h at 65 000 × g. The sediments were 
stored frozen at -20°C. 
2.5. Thioflavine T based fluorimetric assays 
Fluorescence spectra were made on a Shimadzu 
spectrofluorimeter with an assay volume of 1 ml. In all 
studies excitation spectra (400-500 nm) were taken with 
emission collected at 482 nm. Excitation and emission slits 
were set at 5 and 10 nm, respectively. The reaction 
mixture contained 3 /zM thioflavine T and 50 mM 
glycine-NaOH buffer, pH 9 [ 11 ]. Spectra were obtained at 
room temperature within minutes after the addition of the 
sample to the reaction mixture. 
2.6. Congo red binding 
Synthetic amyloid fibrils prepared from wild type TTR 
were incubated with 7/zM congo red in 50 mM Tris pH 
7.5, 100 mM KC1 and examined for green birefringence 
under polarized light in a Olympus polarization light mi- 
croscope [2]. Shifts on absorbance spectra (400-600 nm) 
were analyzed in a Shimadzu dual beam spectrophotom- 
eter. 
2.7. Electron microscopy 
Samples were dried on carbonized formvar coated grids 
(TAAB Laboratories Equipment, UK), negatively stained 
with 1% uranyl acetate and examined in a JEOL 100 CX 
microscope. 
2.8. Other analytical procedures 
Protein concentration was determined using bicin- 
choninic acid (Pierce-BCA assay reagent) with a standard 
curve of bovine serum albumin (range 50-250 /zg/ml). 
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Fig. 1. Thioflavine T binding to native amyloid fibrils. (B) Double 
reciprocal representation f thioflavine T binding to fresh ( • ), K a = 0.16 
/zM, and lyophilized (+),  K~ = 109 NM, amyloid fibrils. Values repre- 
sent the mean of three assays. (A) Fibril concentration dependence urve. 
Used 3 NM thioflavine T and fluorescence was measured at excitation 
maxima at 436 nm and emission maxima at 482 nm. 
Protein content of thyroid amyloid fibrils was deter- 
mined by amino acid analysis. 
3. Results 
Fluorimetric assay with native TTR amyloid fibrils and 
'amyloid-like' fibrils from a synthetic TTR peptide. 
Quantitative fluorimetric assays have been described for 
fibrils of gelsolin, murine senile amyloid protein, murine 
amyloid protein A and /3-peptide [15,11,16] but not for 
TTR amyloid fibrils. Because aquantitative assay is needed 
for 'in vitro' studies, we have tested the suitability of this 
fluorimetric assay for TTR amyloid. 
To start with, amyloid fibrils purified post-mortem from 
the thyroid of an FAP patient were used with assays 
performed on both lyophilized and freshly isolated prepa- 
rations. Upon addition of thioflavine T to suspensions of 
both kinds of preparations, new excitation and emission 
maxima appeared at 450 nm and at 482 nm respectively, 
corresponding to the described maxima in thioflavine T 
spectra fter binding to amyloid fibrils of different natures 
Ill]. 
Using fresh and lyophilized fibrils, fluorescence varia- 
tion at different hioflavine T concentrations was studied 
and the apparent affinity constants determined from double 
reciprocal plots (Fig. 1B); thioflavine T binds to lyophilized 
fibrils (K a = 109 /xM) with lower affinity than to fresh 
fibrils (K a = 0.16 /xM). 
The dependence on fibril concentration was also inves- 
tigated. For values up to 5 /xg per ml of lyopbilized fibrils 
(referring to the total protein content of the fibrils as 
determined by amino acid analysis) the increase in fluores- 
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Fig. 2. Characterization f amyloid like fibrils produced from wild type TTR. (A) Electron micrograph of negatively stained amyloid like fibrils; 
magnification 100000 ×.  (B) Absorbance spectra of congo red (- -), amyloid like fibrils stained with 7/xM congo red ( __ ) ;  the red shift in absorbance 
when congo red binds amyloid is evident. 
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cence was linear with the increase in concentration (Fig. 
1A). 
Therefore this fluorimetric assay can be applied for 
amyloid quantification, but care should be taken concern- 
ing the sample physical-chemical state. From these studies 
we concluded that 3 /zM was the best thioflavine T 
concentration to use in the subsequent assays. 
We have also studied whether the thioflavine T assay 
was suitable for 'amyloid-like' fibrils produced with a 
synthetic heptapeptide (Y649) corresponding to residues 
28 to 33 of human TTR Met30. Y649 (10 mg/ml)  formed 
'amyloid-like' fibrils in 1% acetic acid as detected by 
electron microscopy and congo red staining (data not 
shown). Thioflavine T bound to these fibrils with a lower 
affinity (K a = 0.42 /~M) than to fresh native amyloid 
fibrils, therefore sample origin also influences binding 
affinity of thioflavine T. 
3.1. 'Amyloid-like' formation from wild type TTR 
In order to produce 'amyloid-like' fibrils from wild type 
TTR we used a modification of the described method of 
acidification [17], that is, we lowered the protein concen- 
tration to 2 mg/ml  and increased pH to 4.0. The suspen- 
sions so obtained were centrifuged for 2 h at 65 000 × g, 
the sediments tained with congo red and analyzed by 
polarization microscopy; a characteristic green bire- 
fringence was evident and electron microscopy revealed 
the presence of fibrils resembling amyloid fibrils, with an 
approximate diameter of 9.8 nm (Fig. 2A). 
Congo red binding to these 'amyloid like' fibrils was 
also investigated by spectrophotometry; the characteristic 
5-10 nm red shift and the maximal spectral difference at 
540 nm that occur upon binding of congo red to amyloid 
[18] were also evident (Fig. 2B). 
Protein concentration and pH dependence in amyloid 
formation was quantitatively investigated by the thioflavine 
T assay. In both experiments he incubation time was 96 h 
at room temperature. The amounts of amyloid obtained 
with protein concentrations lower than 1.25 mg/ml  were 
almost negligible; however, for values higher than 3 mg/ml  
a decrease in amyloid formation was observed, suggesting 
that at lower concentrations, amyloid fibril formation is a 
concentration-dependent process and that higher concentra- 
tions are rate limiting (Fig. 3, top). In terms of pH it was 
observed that TTR formed amyloid between values of 2.6 
to 4.6 with a peak at pH 3.6 (Fig. 3, middle). 
The kinetics of the amyloid formation process were also 
determined using 2 mg/ml  of wild type TTR at pH 4 with 
incubation times ranging from 0-100 h. Although amyloid 
formation is almost immediate, different rate steps can be 
distinguished: an initial slower phase of 6 h that is fol- 
lowed by an exponential phase of about 14 h after which 
the rate diminishes to its minimum (Fig. 3, bottom). 
Protein concentration of 2 mg/ml  at pH 4 with an 
incubation time of 96 h at room temperature were the 
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Fig. 3. 'Amyloid- l ike'  fibril formation from wild type TTR by thioflavine 
T based fluorimetry. Fluorescence was measured at excitation maxima at 
436 nm and emission maxima at 482 nm. Values are reported as the mean 
of three assays; +SD (in arbitrary units). (Top) TTR concentration 
dependence curve. (Middle) pH dependence curve. (Bottom) Time-course 
formation of 'amyloid-l ike' fibrils 
conditions eligible for amyloid formation from wild type 
TTR; in these conditions the apparent affinity constant of 
thiofiavine T for the 'amyloid-like' fibrils was 1.33 /xM. 
It should be stressed that the physical-chemical proper- 
ties of different protein batches might interfere with the 
reproducibility of these results in absolute terms; therefore 
we recommend that in all the experiments here should be 
a control of the same protein batch. 
3.2. 'Amyloid like' formation from TTR uariants 
Having available recombinant bacteria producing sev- 
eral TTR variants we have decided to compare the process 
of amyloid formation for these variants as a function of 
pH. The variants chosen were TTR Met30, TTR Pro55 and 
TTR Met119. 
Wild type TTR and TTR variants at a concentration of 
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Fig. 4. pH dependence curve of 'amyloid-l ike' fibril formation of TTR 
variants by quantitative thioflavine T based fluorimetry. Fluorescence was 
measured at excitation maxima at 436 nm and emission maxima at 482 
nm. Values are reported as the mean of three assays; ___ SD (in arbitrary 
units). 
2 mg/ml  were therefore incubated in citrate/phosphate 
buffer at the pH range 2.6-6.0 for 96 h at room tempera- 
ture. At the end of the experiment samples were used for 
fluorimetric determination (Fig. 4). Under the conditions 
tested, the Met119 variant formed very little amounts of 
amyloid and in more acidic conditions than wild type TTR, 
i.e., between pH 2.6-4.0 with a peak at pH 3; this 
indicates a higher stability of this protein and a lower 
degree of amyloidogenicity when compared to the wild 
type TTR, that as already seen, forms amyloid in the range 
of 2.6-4.6 with a peak at pH 3.6. Compared to the wild 
type TTR, the Met30 variant formed higher amounts of 
amyloid with a wider range of pH, i.e. between 2.6-5.0; 
the peak of maximum amyloid formation was the same as 
for wild type TTR; the TTR Pro55 variant had quite a 
different behaviour; not only did it form very high amounts 
of amyloid at pH 3.6-5.0 with almost no difference be- 
tween these pHs (in opposition to the other proteins that 
had a peak at a specific pH), but also the fibrils produced 
by this protein were evident as precipitates that could be 
sedimented at low velocities, e.g. 14500 rpm. 
sis can be raised to explain this fact; sulfate could interfere 
with the fluorimetric assay by either competing with 
thioflavine T for the binding to amyloid or by quenching 
the thioflavine T fluorescence; sulfate could favour the 
aggregation of amyloid fibrils, similarly to the effect re- 
ported for/3-peptide [19], thus limiting the accessibility of 
the thioflavine T for binding sites on amyloid; finally 
sulfate could inhibit the polymerization of the protein into 
amyloid. 
To distinguish between these hypotheses we designed 
an experiment where a set of three tubes containing wild 
type TTR at the standard conditions were prepared; 50 
mM sodium sulfate were added to one of the tubes and 
after 24 h of incubation 50 mM sodium sulfate were added 
to another tube. 48 h later samples were used for fluorime- 
try without any further treatment. It was observed that the 
time of addition of sulfate was the determining factor, in 
that more fluorescence was detected with shorter incuba- 
tion times (data not shown). It appears unlikely that sulfate 
competes with thioflavine T for binding to amyloid or 
quenches thioflavine T fluorescence, but rather interferes 
with the inhibition of the protein polymerization i to amy- 
loid and/or promotes the aggregation of fibrils limiting 
the accessibility of thioflavine T to the amyloid fibrils. 
In order to get some more insights into the effect of 
sulfate in fibril formation a kinetic study was performed 
with TTR Pro55, 2 mg/ml  at pH 4.6 in the presence and 
absence of sulfate; at the end of the experiment samples 
were spun in a microfuge, sediments analyzed by fluorime- 
try and supernatants used for protein quantification. The 
rate of amyloid formation was the same in the presence or 
in the absence of sulfate, but the amount of amyloid 
formed in the absence of sulfate was higher (Fig. 5); 
however the protein remaining soluble in the supernatant 
was the same in both cases. Therefore sulfate probably 
also favours the formation of amorphous precipitates, 
counteracting the polymerization of the protein into amy- 
loid. In order to exclude thioflavine T binding to amor- 
phous precipitates 10% trichloroacetic acid was used for 
3.3. Influence of sulfate in amyloid formation 
Native amyloid fibrils are known to have associated 
glycosaminoglycans, which are highly sulfated carbo- 
hydrates. In order to study the influence of sulfate ions in 
the process of amyloid formation we started by incubating 
wild type TTR at standard conditions (2 mg/ml,  pH 4) 
with 50 mM sodium sulfate; after about 1 hour the solution 
became turbid and by 96 hours of incubation, a large 
sediment was visible. After centrifugation i a microfuge 
both sediment and supernatant were used for fluorimetry. 
No detectable fluorescence was seen in the supernatant, 
but the presence of amyloid was evident in the sediment, 
although the fluorescence intensity was lower than in the 
control without sulfate (data not shown). Several hypothe- 
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Fig. 5. Time course formation of 'amyloid-l ike' fibrils from TTR Pro55 
in the presence (- -) or absence ( __ )  of 50 mM sodium sulfate. 
Fluorescence was measured at excitation maxima at 436 nm and emission 
maxima at 482 nm. Values are reported as the mean of three assays; 
J: SD (in arbitrary units). 
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precipitating a 2 mg/ml solution of wild type TTR at 
room temperature; the precipitate obtained id not induced 
novel maximas of thioflavine T when studied in fluorime- 
try (data not shown). It was also observed that the addition 
of sulfate to 'in vitro' pre-formed amyloid fibrils led to the 
aggregation and precipitation of the fibrils, further corrob- 
orating the effect of promotion of fibril macroaggregation. 
3.4. Influence of metals in amyloid formation 
In order to study the influence of A1CI 3, ZnCI 2, MgC12 
and NaCI in the process of amyloid formation from TTR 
we assessed in the first place whether these ions interfered 
with the thioflavine T fluorimetric assay; amyloid formed 
in the standard conditions from wild type TTR was quanti- 
fied by thioflavine T, and then each of the salts to test 
were added and the mixture quantified again. It was ob- 
served that both aluminum, zinc and magnesium interfered 
with the thioflavine T assay though at different concentra- 
tions; for concentrations higher than 1 mM aluminum and 
zinc reduced the fluorescence of thioflavine T bound to 
amyloid fibrils whereas only concentrations higher than 10 
mM of magnesium interfered with the assay; as for sodium, 
it did not have any effect on the assay. We have therefore 
tested the following concentrations of salts in the process 
of amyloid formation: 500 /zM and 1 mM of aluminum 
and zinc, 500/xM, 1 mM and 10 mM of magnesium and 
150 mM sodium. No effect was observed with any of these 
concentrations in the process of amyloid formation from 
wild type TTR (data not shown). 
4. Discussion 
Several approaches have been applied to study amyloid 
formation 'in vitro'; synthetic peptides, corresponding to
either fragments or the whole protein, have been useful to 
define the amyloidogenic regions of protein precursors 
such as in the case of gelsolin [15,20], protein AA [21], 
/3-peptide [22,23], islet amyloid polypeptide [24] or TTR 
[17,25]. One very important aspect that needs to be ad- 
dressed when dealing with 'in vitro' assays is the method- 
ology used to assess the presence of amyloid; the charac- 
teristic apple-green birefringence under polarized light af- 
ter staining with congo red, the yellow green fluorescence 
upon staining with thioflavine S and the ultrastructural 
characterization by electron microscopy are the most used 
methods; X-ray diffraction analysis was also performed in 
some instances [25,26]. As for quantification of amyloid, 
congo red spectrophotometry hasbeen successfully applied 
[18] and in 1989, Naiki et al. developed a quantitative 
method for murine senile amyloid protein (ASSA M) a 
murine amyloid protein A (AA), using thioflavine T based 
fluorimetry [11]. This methodology has been applied for 
other amyloid proteins uch as gelsolin [20] and /3-peptide 
[16,27]. 
Other strategies developed as anattempt toelucidate the 
mechanisms of amyloid formation included the use of 
metal ions and other agents, in the production of amyloid 
as in the case of /3-AP [28,19,29]; for instance, induction 
of aggregation of /3-A4 by means of metal catalyzed 
oxidation [30] and aggregation kinetics of synthetic pep- 
tides and natural variants of /3-protein [31] have been 
reported. 
In order to assess factors that might be involved in the 
process of amyloid fibril formation in FAP, we studied the 
process of 'in vitro' amyloid formation from wild type and 
variant TTR using thioflavine T based fluorimetry. 
The suitability of thioflavine T fluorimetry as a quanti- 
tative method already described for other amyloids was 
here tested and optimized for native TTR amyloid. It was 
noticed that the physical-chemical state of the amyloid 
fibril preparations influenced their affinity for thioflavine 
T; dehydration might originate either a different orienta- 
tion of the fibrils or a more aggregated state altering the 
accessibility of thioflavine T molecules. Care should be 
taken therefore, when using this methodology, to differ- 
ences in the physical-chemical state of the samples. 
The production of 'in vitro' amyloid formation from 
TTR (both wild type TTR and synthetic peptides) by 
acidification of the protein solutions [17,25] has already 
been described. We used a modification of these methods 
to produce 'amyloid-like' fibrils, from wild type TTR, and 
characterized the fibrils by the characteristic green bire- 
fringence under polarized light upon congo red staining, 
and by the appearance on electron microscopy. The pro- 
cess of amyloid formation was more thoroughly studied at 
different pH conditions and at different TTR concentra- 
tions by quantitative thioflavine T based fluorimetry; we 
found that wild type TTR forms amyloid in a pH range of 
2.6-4.6, with higher yields of amyloid being obtained at 
pH 3.6. Colon and Kelly [32] reported amyloid formation 
from TTR at pH 3.3-4.5, but not at pH 2.5; stating that at 
this pH there is a transition from tetramer to monomer 
with loss of the tertiary structure. These authors consider 
that at this pH only very small amounts of amyloid would 
form. With the conditions used we clearly have detected 
amyloid formation at pH 2.6, probably also due to the 
sensitivity of thioflavine T fluorimetry. The concentration 
of the protein is also an important factor our 'in vitro' 
studies, as for protein concentrations below 0.75 mg/ml 
very little amyloid is formed; protein concentrations of
2-3 mg/ml appear to maximize the amounts of amyloid 
formed and above 5 mg/ml, again less amyloid is ob- 
tained, probably because highly populated solutions might 
favour some random aggregation, instead of oriented poly- 
merization into amyloid fibrils. Other authors report 'in 
vitro' amyloid formation at protein concentrations of 0.6 
mg/ml [32] and 10 mg/ml [17]; however these reports did 
not apply quantitative or specific methods for amyloid 
evaluation, by using electron microscopy [17] and light 
scattering [32]. 
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The amyloidogenicity of different mutations in the TTR 
molecule was compared. The variants chosen were TTR 
Met30, the most prevalent mutation in FAP, TTR Pro55, 
the most pathologically devastating mutation known to 
date, and TTR Met119 a mutation apparently not associ- 
ated with amyloid deposition. 
By spectroscopy, glutaraldehyde cross-linking studies, 
and SDS-PAGE analysis, the acid-mediated denaturation 
pathway of wild type TTR in the presence or absence of 
Z3-14 (a detergent inhibitor of fibril formation) was inves- 
tigated by Colon and Kelly [32]; these authors propose that 
at pH 4.4 there is an equilibrium of tetramer to a structured 
amyloidogenic monomer intermediary, with the formation 
of amyloid fibrils, the 'amyloidogenic ntermediate' hy- 
pothesis for amyloid formation [33]; upon lowering the pH 
to 3.3, he monomer undergoes a further rearrangement 
lacking the ability to form amyloid [32]. Following this 
methodology, the behaviour of TTR Met30 and TTR Pro55 
was compared; the Met30 tetramer was shown to have a 
lower stability than the wild type tetramer with a pHm 
value of 4.7 (pHm = midpoint of tetramer to monomer 
equilibrium) but a much higher stability than the Pro55 
tetramer (pHm = 5.35). It was hypothesized that these 
mutations in the TTR molecule destabilize the tetramer 
allowing an amyloidogenic ntermediate o be formed un- 
der milder acidic conditions [12]. 
When we studied TTR Pro55 in a pH dependent assay 
we observed that this mutation was more susceptible to 
amyloid formation, even at higher pHs, than wild type 
TTR; these results are in agreement with the more aggres- 
sive pathological condition associated with this mutation 
[9]. As for the Met119 variant, in opposition to the Pro55, 
only at very acidic conditions did it form small amounts of 
amyloid, showing that this variant is more resistant o 
amyloid formation. On the light of the 'amyloidogenic 
intermediate' hypothesis lbr amyloid formation (see above), 
this mutation could 'stabilize' the TTR tetramer as to the 
conformational change needed to generate the amyloido- 
genic intermediate. Indeed carriers for this mutation have 
no amyloid deposits and no correlated clinical pathology 
[10]. 
Glycosaminoglycans (GAGs) are highly sulfated carbo- 
hydrates that are found to be associated with amyloid 
deposits regardless of the type of amyloid protein in- 
volved; their role in amyloidogenesis is at present un- 
known. It has been suggested [34] that GAGs might en- 
hance the stability of pre-formed fibrils decreasing there- 
fore, their susceptibility to proteolysis; another possible 
role could be in the determination f the anatomical distri- 
bution of the amyloid deposits and finally, GAGs were 
also hypothesized to play a role in the conformational 
folding of precursor amyloidogenic proteins; however, the 
fact that several intact amyloid proteins and/or synthetic 
peptides to portions of amyloid proteins form amyloid 'in 
vitro' [17,22,35,36] argues against his latter hypothesis. 
In our system, when we studied the influence of sulfate 
ions in the process of amyloid formation in our system, we 
observed that sulfate diminished the amount of amyloid 
formed from wild type TTR, probably by favouring ran- 
dom aggregation of TTR protein versus oriented poly- 
merization into amyloid fibrils. A recent article from 
Kisilevsky et al. [37] likewise reports the inhibition of 
amyloidosis 'in vivo' using small-molecule anionic sul- 
fonates. In addition our results suggest that 'in vivo' 
sulfate groups could interact with pre-existing amyloid 
fibrils by promoting their aggregation; macromolecular 
aggregation together with binding of other factors, such as 
P component, may prevent the proteolysis and degradation 
of amyloid deposits [38]. 
TTR was reported to have zinc binding affinity; zinc 
has been also reported to promote aggregation of TTR, 
which could be solubilized by magnesium [39]. In our 
system however, neither zinc or magnesium had any effect 
on amyloid formation form wild type TTR in any of the 
concentrations tested; we have also tested several concen- 
trations of aluminum and sodium but again no effect was 
observed in amyloid formation. Several reports describe 
the involvement of metals in the aggregation of the /3- 
peptide, namely zinc [28] and aluminum [29] however the 
two proteins are structurally distinct and therefore correla- 
tions are hard to draw. 
The influence of factors, including therapeutical gents, 
on TTR amyloid formation can be investigated following 
the described methodology, and the amyloidogenecity of 
different TTR variants compared. 
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